Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $2.79 Million - $3.75 Million
40,211 New
40,211 $2.79 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $2.22 Million - $2.89 Million
26,958 New
26,958 $2.23 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $987,539 - $1.21 Million
-9,284 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $955,416 - $1.14 Million
9,284 New
9,284 $1.05 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $1.13 Million - $1.41 Million
-13,503 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $550,209 - $634,055
6,993 Added 107.42%
13,503 $1.13 Million
Q4 2020

Feb 11, 2021

BUY
$71.69 - $91.23 $466,701 - $593,907
6,510 New
6,510 $594,000
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $127,738 - $170,829
-2,220 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $121,119 - $187,191
-2,311 Reduced 51.0%
2,220 $419,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $324,872 - $371,949
4,531 New
4,531 $1.06 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $420,201 - $514,960
-6,827 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $380,536 - $439,727
6,827 New
6,827 $1.26 Million
Q1 2019

May 13, 2019

SELL
$47.89 - $64.05 $131,984 - $176,521
-2,756 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $127,905 - $156,926
2,756 New
2,756 $422,000
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $296,867 - $376,962
-6,496 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $38,035 - $45,964
896 Added 16.0%
6,496 $945,000
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $208,264 - $265,720
5,600 New
5,600 $782,000
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $334,149 - $389,527
-9,889 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $358,871 - $383,989
9,889
9,889 $1.08 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.